Evidence map›Paper›PMID 37198020›Full record

Trial reportVaccine2023

Personal risk or societal benefit? Investigating adults' support for COVID-19 childhood vaccination.

Chiara Chiavenna, Laura P Leone, Alessia Melegaro, Tiziano Rotesi, Scott E Bokemper, Elliott E Paintsil, Amyn A Malik, Gregory A Huber, Saad B Omer, Maria Cucciniello and 1 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Chiara ChiavennaBocconi University, Dondena Centre for Research on Social Dynamics and Public Policies, Milan, Italy; Bocconi University, Bocconi Institute for Data Science and Analytics (BIDSA), Milan, Italy.
Laura P LeoneBocconi University, Dondena Centre for Research on Social Dynamics and Public Policies, Milan, Italy.
Alessia MelegaroBocconi University, Dondena Centre for Research on Social Dynamics and Public Policies, Milan, Italy; Bocconi University, Bocconi Institute for Data Science and Analytics (BIDSA), Milan, Italy; Bocconi University, Social and Political Science Department, Milan, Italy. Electronic address: alessia.melegaro@unibocconi.it.
Tiziano RotesiUniversity of Lausanne, Department of Economics, Lausanne, Switzerland.
Scott E BokemperYale University, Institution for Social and Policy Studies, New Haven, CT, USA; Yale University, Center for the Study of American Politics, New Haven, CT, USA.
Elliott E PaintsilYale Institute for Global Health, New Haven, CT, USA.
Amyn A MalikYale Institute for Global Health, New Haven, CT, USA; Yale School of Medicine, New Haven, CT, USA.
Gregory A HuberYale University, Institution for Social and Policy Studies, New Haven, CT, USA; Yale University, Center for the Study of American Politics, New Haven, CT, USA; Yale University, Department of Political Science, New Haven, CT, USA.
Saad B OmerYale Institute for Global Health, New Haven, CT, USA; Yale School of Medicine, New Haven, CT, USA; Yale School of Public Health, New Haven, CT, USA; Yale School of Nursing, Orange, CT, USA.
Maria CuccinielloBocconi University, Dondena Centre for Research on Social Dynamics and Public Policies, Milan, Italy; University of Edinburgh, Business School, Edinburgh, Scotland.
Paolo PinBocconi University, Bocconi Institute for Data Science and Analytics (BIDSA), Milan, Italy; Università di Siena, Department of Economics and Statistics, Siena, Italy.
Bocconi University · ITYale University · USUniversity of Lausanne · CHUniversity of Siena · IT

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Parental hesitancy poses a serious threat to the success of the COVID-19 childhood vaccination campaign. We investigate whether adults' opinions on childhood vaccination can be influenced via two survey experiments in Italy (n = 3,633 participants) and the UK (n = 3,314 participants). Respondents were randomly assigned to: a "risk treatment" that highlighted the potential risks of COVID-19 to a child, a "herd immunity treatment" that emphasized the community benefits of pediatric vaccination, or a control message. Participants' probability of supporting COVID-19 childhood vaccination was then assessed on a 0-100 scale. We find that the "risk treatment" reduced the proportion of Italian parents strongly against vaccination by up to 29.6 %, while increasing the proportion of neutral parents by up to 45.0 %. The "herd immunity treatment", instead, was only effective among non-parents, resulting in a lower proportion of individuals against pediatric vaccination and a higher proportion of individuals in favor (both shifted by around 20 %).

Indexed as

COVID-19AdultChildHumansImmunity, HerdImmunization ProgramsItalyVaccinationChildrenCOVID-19Health informationParentsVaccine hesitancy

Identifiers

PMID37198020
PMCPMC10167374
OpenAlexW4377010765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.